PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Journal of Clinical Medicine0 citationsOpen Access

Common Variable Immune Deficiency and Pregnancy: Improving Outcomes Through Multidisciplinary Care

View Full Paper
FAFatemah AlYaqoutMAMichael AwESEisa Saleh

Key Points

  • This research aims to explore effective management strategies for women with Common Variable Immune Deficiency (CVID) during pregnancy to improve maternal and fetal outcomes.
  • Performed a narrative review of the literature on pregnancy outcomes in CVID.
  • Conducted a 10-year retrospective chart review of pregnant women with CVID at McGill University Health Centre from 2015 to 2025.
  • Pregnancy outcomes were improved with pre-conception planning and regular IgG monitoring.
  • Trimester-based immunoglobulin dose adjustments and proactive management of complications enhanced outcomes.
  • Subcutaneous immunoglobulin provided better IgG level stability compared to other routes.

Abstract

Background: Pregnancy presents unique immunological and obstetrical challenges for women with Common Variable Immune Deficiency (CVID). No standardized guidelines currently exist to guide pregnancy management, as CVID is a rare diagnosis, with pregnancy outcomes limited to case reports and case series. Establishing a structured approach to care is important to optimize maternal and fetal outcomes. Methods: A narrative review of the literature with a structured search was performed to detail pregnancy outcomes in CVID and management strategies. A 10-year retrospective chart review of women with CVID who became pregnant while receiving care at the McGill University Health Centre between January 2015 and January 2025 was conducted to add to the existing clinical data. Results: Pregnancy outcomes were improved through pre-conception planning, regular serum Immunoglobulin G (IgG) monitoring, trimester-based immunoglobulin replacement dose adjustments, proactive management of autoimmune or infectious complications, and multidisciplinary care. Subcutaneous immunoglobulin may offer better flexibility and stability of IgG levels. Conclusions: In the available observational literature and our institutional experience, many patients with CVID have carried pregnancies to term with favorable maternal and neonatal outcomes when managed with IgRT and multidisciplinary coordination. We outline a stepwise multidisciplinary framework for clinicians caring for women with CVID who are planning or undergoing pregnancy, and we identify gaps in knowledge for future studies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

AlYaqout et al. (2026) studied this question.

synapsesocial.com/papers/6a095bdd7880e6d24efe1c58https://doi.org/10.3390/jcm15103810
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study2025 · 6 citations
  2. 2Update on the Use of Intravenous Immunoglobulin in Pregnancy2021 · 26 citations
  3. 3Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study2025 · 39 citations
  4. 4Rapid Subcutaneous IgG Replacement Therapy at Home for Pregnant Immunodeficient Women2001 · 58 citations
  5. 5A scoping review of clinical management guidelines in inborn errors of immunity2025 · 7 citations